Case Study

From Concept To Reality: Fujifilm Forges A Path To Future Growth With SUT

Source: GE Healthcare Life Sciences

By Stewart McNaull, Ph.D., Fujifilm Diosynth

antibody

In 2009, Fujifilm Diosynth Biotechnologies (Fujifilm), a biologics CDMO for over 20 years, sought to expand its cell culture operations to meet the industry’s need for more manufacturing capacity. Fujifilm began to look at single-use technology (SUT), and questioned if it offered the same performance as stainless steel when it came to cell growth, cellular productivity, and product quality? By learning the answer to this question and others about SUT, Fujifilm was able to use its knowledge as early adopters, expand its business capabilities, and, as a result, look forward to new growth well into the future.